Sign Up to like & get recommendations! 1
Published in 2022 at "Advances in Therapy"
DOI: 10.1007/s12325-021-02031-y
Abstract: Homozygous familial hypercholesterolaemia (HoFH) is characterised by extremely elevated levels of low-density lipoprotein cholesterol (LDL-C) and results from multiple mutations in genes affecting the LDL receptor pathway. Patients are at risk of premature atherosclerotic cardiovascular… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2017.01.015
Abstract: BACKGROUND AND AIMS Homozygous familial hypercholesterolaemia (HoFH) is a rare inherited condition characterized by elevated plasma low-density lipoprotein-cholesterol (LDL-C) levels, severe, accelerated atherosclerosis and premature coronary heart disease. We evaluated cardiovascular complications in HoFH patients… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2018.01.005
Abstract: BACKGROUND AND AIMS Maximizing the acute reduction of LDL-cholesterol (C) and lipoprotein (a) (Lp(a)) concentrations in patients with homozygous familial hypercholesterolemia (HoFH) is the main goal of lipoprotein apheresis (LA). The objective of this study… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2022.03.015
Abstract: BACKGROUND AND AIMS Homozygous familial hypercholesterolemia (HoFH) is characterized by severely elevated low-density lipoprotein cholesterol (LDL-C) levels leading to extremely premature atherosclerotic cardiovascular disease. Therefore, healthcare professionals consider HoFH to have major impact on patients'… read more here.
Sign Up to like & get recommendations! 2
Published in 2017 at "Journal of clinical lipidology"
DOI: 10.1016/j.jacl.2017.09.001
Abstract: Identification of a patient homozygous for familial defective apolipoprotein B-100(FDB) and successful treatment with PCSK9 inhibition. read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Journal of clinical lipidology"
DOI: 10.1016/j.jacl.2020.01.009
Abstract: A 28-year-old woman with a rare combination of homozygous LDLR and heterozygous PCSK9 mutations had a phenotype consistent with homozygous familial hypercholesterolemia. She reported a clinical history of coronary and extracoronary atherosclerosis treated with 3… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2021.1862083
Abstract: ABSTRACT Introduction: Homozygous Familial Hypercholesterolemia (HoFH) is a very severe genetic form of hypercholesterolemia. Lacking LDL receptors in the liver, subjects with HoFH have raised plasma levels of LDL cholesterol, and up to 100 times… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2022.2047934
Abstract: ABSTRACT Introduction Hypercholesterolemia is mainly caused by abnormal lipoprotein metabolism and can increase the risk of cardiovascular disease. Angiopoietin-like protein 3 (ANGPTL3) can increase low-density lipoprotein cholesterol (LDL-C) and other lipids by inhibiting lipoprotein lipase… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Expert Opinion on Orphan Drugs"
DOI: 10.1080/21678707.2020.1784721
Abstract: ABSTRACT Introduction Homozygous familial hypercholesterolemia (hoFH), a genetic disorder characterized by markedly impaired hepatic clearance of LDL and LDL cholesterol concentration exceeding 12 mmol/L, causes coronary artery and aortic valve disease before adulthood. The hoFH… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "European heart journal"
DOI: 10.1093/eurheartj/ehac339
Abstract: AIMS Homozygous familial hypercholesterolaemia (HoFH) is an orphan disease defined by extreme elevations in low-density lipoprotein cholesterol, cutaneous xanthomas, and pre-mature atherosclerotic cardiovascular disease. Survival has more than doubled over the past three decades. Aortic… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Current Opinion in Lipidology"
DOI: 10.1097/mol.0000000000000853
Abstract: Purpose of review We reviewed current and future therapeutic options for patients with homozygous familial hypercholesterolemia (HoFH) and place this evidence in context of an adaptable treatment algorithm. Recent findings Lowering LDL-C levels to normal… read more here.